MARC details
| 000 -LEADER |
| fixed length control field |
14163cam a22008174a 4500 |
| 001 - CONTROL NUMBER |
| control field |
ocm52314871 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250702164221.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
990714s2000 njua ob 001 0 eng c |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
| LC control number |
99038474 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
COO |
| Language of cataloging |
eng |
| Description conventions |
pn |
| Transcribing agency |
COO |
| Modifying agency |
N$T |
| -- |
YDXCP |
| -- |
CUV |
| -- |
ZCU |
| -- |
GW5XE |
| -- |
CUS |
| -- |
YNG |
| -- |
CSU |
| -- |
OCLCQ |
| -- |
PUL |
| -- |
CNTRU |
| -- |
OCLCE |
| -- |
E7B |
| -- |
CASUM |
| -- |
IDEBK |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
OCLCF |
| -- |
OCLCQ |
| -- |
AZU |
| -- |
OCLCQ |
| -- |
EUW |
| -- |
OCLCQ |
| -- |
OCL |
| -- |
OCLCQ |
| -- |
VT2 |
| -- |
OCLCA |
| -- |
OTZ |
| -- |
STF |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
BUF |
| -- |
OCLCO |
| -- |
MERER |
| -- |
KIJ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
U3W |
| -- |
OCLCQ |
| -- |
UWO |
| -- |
YOU |
| -- |
CANPU |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
AU@ |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
OCLCO |
| -- |
GW5XE |
| -- |
U3G |
| -- |
S2H |
| -- |
OCLCA |
| -- |
OCL |
| -- |
OCLCA |
| -- |
INARC |
| -- |
OCLCQ |
| -- |
U9X |
| -- |
OCLCO |
| -- |
OCLCQ |
| -- |
WSU |
| -- |
OCLCO |
| -- |
OCLCL |
| -- |
OCLCQ |
| 019 ## - |
| -- |
232301989 |
| -- |
320972107 |
| -- |
505721968 |
| -- |
606281815 |
| -- |
609341201 |
| -- |
642459997 |
| -- |
771201737 |
| -- |
964889446 |
| -- |
967616717 |
| -- |
994752149 |
| -- |
1005828701 |
| -- |
1027508621 |
| -- |
1045331211 |
| -- |
1050763795 |
| -- |
1055341350 |
| -- |
1066975281 |
| -- |
1078128557 |
| -- |
1078834637 |
| -- |
1078846975 |
| -- |
1081197490 |
| -- |
1086440314 |
| -- |
1087323777 |
| -- |
1117245378 |
| -- |
1119430633 |
| -- |
1148142134 |
| -- |
1152975318 |
| -- |
1153287623 |
| -- |
1154212217 |
| -- |
1228597752 |
| -- |
1264879448 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781592590865 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0896038432 |
| Qualifying information |
(comb ; |
| -- |
alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780896038431 |
| Qualifying information |
(comb ; |
| -- |
alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1592590861 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
9780896037144 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
0896037142 |
| Qualifying information |
(hard ; |
| -- |
alk. paper) |
| 024 7# - OTHER STANDARD IDENTIFIER |
| Standard number or code |
10.1385/1592590861 |
| Source of number or code |
doi |
| 029 1# - (OCLC) |
| OCLC library identifier |
NZ1 |
| System control number |
15211679 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)52314871 |
| Canceled/invalid control number |
(OCoLC)232301989 |
| -- |
(OCoLC)320972107 |
| -- |
(OCoLC)505721968 |
| -- |
(OCoLC)606281815 |
| -- |
(OCoLC)609341201 |
| -- |
(OCoLC)642459997 |
| -- |
(OCoLC)771201737 |
| -- |
(OCoLC)964889446 |
| -- |
(OCoLC)967616717 |
| -- |
(OCoLC)994752149 |
| -- |
(OCoLC)1005828701 |
| -- |
(OCoLC)1027508621 |
| -- |
(OCoLC)1045331211 |
| -- |
(OCoLC)1050763795 |
| -- |
(OCoLC)1055341350 |
| -- |
(OCoLC)1066975281 |
| -- |
(OCoLC)1078128557 |
| -- |
(OCoLC)1078834637 |
| -- |
(OCoLC)1078846975 |
| -- |
(OCoLC)1081197490 |
| -- |
(OCoLC)1086440314 |
| -- |
(OCoLC)1087323777 |
| -- |
(OCoLC)1117245378 |
| -- |
(OCoLC)1119430633 |
| -- |
(OCoLC)1148142134 |
| -- |
(OCoLC)1152975318 |
| -- |
(OCoLC)1153287623 |
| -- |
(OCoLC)1154212217 |
| -- |
(OCoLC)1228597752 |
| -- |
(OCoLC)1264879448 |
| 037 ## - SOURCE OF ACQUISITION |
| Source of stock number/acquisition |
00012511 |
| 042 ## - AUTHENTICATION CODE |
| Authentication code |
pcc |
| -- |
dlr |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RC271.G45 |
| Item number |
G484 2000 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QZ 266 |
| Item number |
G3259 2000 |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MED |
| Subject category code subdivision |
062000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
HEA |
| Subject category code subdivision |
039030 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MJCL |
| Source |
bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
616.99/4042 |
| Edition number |
21 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
| Title |
Gene therapy of cancer : |
| Remainder of title |
methods and protocols / |
| Statement of responsibility, etc. |
edited by Wolfgang Walther and Ulrike Stein. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc. |
Totowa, N.J. : |
| Name of publisher, distributor, etc. |
Humana Press, |
| Date of publication, distribution, etc. |
©2000. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (xvi, 645 pages) : |
| Other physical details |
illustrations |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
| Series statement |
Methods in molecular medicine ; |
| Volume/sequential designation |
35 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 500 ## - GENERAL NOTE |
| General note |
Immunizing potential of cytokine-transduced tumor cells / M.P. Colombo and M. Rodolfo-Particle-mediated gene transfer into dendritic cells : A novel strategy for the induction of immune responses against tumor antigens / T. Tuting and A. Albers-Cancer gene therapy with heat shock protein-65 gene / K.V. Lukacs and A. Nakakes-Recombinant vaccinia virus mva for generation and analysis of t cell responses against tumor associated antigens / I. Drexler [and others]-Selection of cytochrome p450 genes for use in prodrug activation-based cancer gene therapy / J.E. Hecht and D.J. Waxman-Construction of p450-expressing tumor cell lines using retroviruses / J.E. Hecht, Y. Jounaidi and D.J. Waxman-7 in vitro methods for evaluation of p450-based anticancer gene therapy / D.H. JE and D.J. Waxman-8 tumor models for evaluation of p450 gene therapy in vivo / J.E. Hecht, P. Schreiber Schwartz and D.J. Waxman-9 intracellular single-chain antibodies for gene therapy / G. Bilbao [and others]-Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosis / K. Brand, V. Sandig and M. Strauss-Inhibition of cell growth by antisense oligonucleotides targeting the growth-related protein kinase c-raf / D. Fabbro [and others]-Igf-1 antisense strategies for cancer treatment / Y.X. Pan and D.D. Anthony-Anti-mdr1 ribozyme gene therapy / T. Ohnuma, H. Kobayashi and F.S. Wang-Anti-c-erb1b2 ribozyme for gene therapy of breast cancer / T. Suzuki, M. Bessho and K.J. Scanlon-Anti-k-ras1 ribozyme adenoviral vector for gene therapy of non-small cell lung cancer / Y.A. Zhang, J. Nemunaitis and A.W. Tong-Green fluorescent protein retroviral vector : Generation of high-titer producer cells and virus supernatant / W. Uckert, L. Pedersen and W. Gunzburg-Hsv-1 vectors for gene therapy of experimental cns tumors / U. Herrlinger [and others]-Intratumoral injection of naked DNA / J. Yang-Cationic liposome gene transfer / K. Kay Son-In vivo particle-mediated gene transfer for cancer therapy / A.L. Rakhmilevich and N.S. Yang-Gene targeting to hepatomas (afp) / S. Tsuruta, A. Ido and S. Nagataki-Adenovirus-mediated targeted gene therapy for breast cancer and for purging hematopoietic stem-cell sources / L. Chen-Chemotherapy-inducible vector for gene therapy of cancer / W. Walther [and others]-Oncolytic adenoviral vectors / R. Alemany and W.W. Zhang-Genetically modified clostridium for gene therapy of tumors / M.E. Fox [and others]-Tumor-targeted salmonella: Strain development and expression of the hsv-tk effector gene / D. Bermudes, B. Low and J.M. Pawelek-Ex vivo cytokine gene transfer in melanomas by using particle bombardment / D. Schadendorf-Intratumoral gene transfer of the hla-b7 gene into colon carcinoma metastases / E. Galanis and J. Rubin-Hybrid cell vaccination in patients with metastatic melanoma / U. Trefzer [and others]-Retroviral transfer of the herpes simplex virus-thymidine kinase (hsv-tk) gene for the treatment of cancer / R. Ramesh [and others]-Gene therapy for treatment of brain tumors (hsv-tkin vivo gene transfer) : A case study / F. Weber, F. Floeth and H. Bojar-Gene therapy of glioblastoma multiforme with a bicistronic retroviral vector expressing human il-2 and hsv-tk / G. Palu [and others]-Intratumoral gene transfer of the cytosine deaminase gene for the treatment of breast cancer / H.S. Pandha and N.R. Lemoine-Adenovirus-mediated wild-type p53 gene transfer into head and neck cancers / G.L. Clayman, D.K. Frank and P.A. Bruso-Direct DNA injection (p53) into hcc tumors / R.R. Mitry and N.A. Habib-A phase ii trial of intratumoral injection with a selectively replicating adenovirus (onyx-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck / D.H. Kirn-C-myb antisense oligonucleotide therapeutics for hematologic malignancies / S. Luger-Ovarian cancer gene therapy with brca1-an overview / P.S. Obermiller and J.T. Holt-Methods for chemoprotection and chemosensitization : Mdr-1 for chemoprotection using retroviruses to modify hematopoietic cells and cytosine deaminase for chemosensitization using adenoviral vectors to modify epithelian neoplastic cells / S. Shrimdkandada [and others]. |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Immunizing potential of cytokine-transduced tumor cells / M.P. Colombo and M. Rodolfo-Particle-mediated gene transfer into dendritic cells : A novel strategy for the induction of immune responses against tumor antigens / T. Tuting and A. Albers-Cancer gene therapy with heat shock protein-65 gene / K.V. Lukacs and A. Nakakes-Recombinant vaccinia virus mva for generation and analysis of t cell responses against tumor associated antigens / I. Drexler [and others]-Selection of cytochrome p450 genes for use in prodrug activation-based cancer gene therapy / J.E. Hecht and D.J. Waxman-Construction of p450-expressing tumor cell lines using retroviruses / J.E. Hecht, Y. Jounaidi and D.J. Waxman-7 in vitro methods for evaluation of p450-based anticancer gene therapy / D.H. JE and D.J. Waxman-8 tumor models for evaluation of p450 gene therapy in vivo / J.E. Hecht, P. Schreiber Schwartz and D.J. Waxman-9 intracellular single-chain antibodies for gene therapy / G. Bilbao [and others]-Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosis / K. Brand, V. Sandig and M. Strauss-Inhibition of cell growth by antisense oligonucleotides targeting the growth-related protein kinase c-raf / D. Fabbro [and others]-Igf-1 antisense strategies for cancer treatment / Y.X. Pan and D.D. Anthony-Anti-mdr1 ribozyme gene therapy / T. Ohnuma, H. Kobayashi and F.S. Wang-Anti-c-erb1b2 ribozyme for gene therapy of breast cancer / T. Suzuki, M. Bessho and K.J. Scanlon-Anti-k-ras1 ribozyme adenoviral vector for gene therapy of non-small cell lung cancer / Y.A. Zhang, J. Nemunaitis and A.W. Tong-Green fluorescent protein retroviral vector : Generation of high-titer producer cells and virus supernatant / W. Uckert, L. Pedersen and W. Gunzburg-Hsv-1 vectors for gene therapy of experimental cns tumors / U. Herrlinger [and others]-Intratumoral injection of naked DNA / J. Yang-Cationic liposome gene transfer / K. Kay Son-In vivo particle-mediated gene transfer for cancer therapy / A.L. Rakhmilevich and N.S. Yang-Gene targeting to hepatomas (afp) / S. Tsuruta, A. Ido and S. Nagataki-Adenovirus-mediated targeted gene therapy for breast cancer and for purging hematopoietic stem-cell sources / L. Chen-Chemotherapy-inducible vector for gene therapy of cancer / W. Walther [and others]-Oncolytic adenoviral vectors / R. Alemany and W.W. Zhang-Genetically modified clostridium for gene therapy of tumors / M.E. Fox [and others]-Tumor-targeted salmonella: Strain development and expression of the hsv-tk effector gene / D. Bermudes, B. Low and J.M. Pawelek-Ex vivo cytokine gene transfer in melanomas by using particle bombardment / D. Schadendorf-Intratumoral gene transfer of the hla-b7 gene into colon carcinoma metastases / E. Galanis and J. Rubin-Hybrid cell vaccination in patients with metastatic melanoma / U. Trefzer [and others]-Retroviral transfer of the herpes simplex virus-thymidine kinase (hsv-tk) gene for the treatment of cancer / R. Ramesh [and others]-Gene therapy for treatment of brain tumors (hsv-tkin vivo gene transfer) : A case study / F. Weber, F. Floeth and H. Bojar-Gene therapy of glioblastoma multiforme with a bicistronic retroviral vector expressing human il-2 and hsv-tk / G. Palu [and others]-Intratumoral gene transfer of the cytosine deaminase gene for the treatment of breast cancer / H.S. Pandha and N.R. Lemoine-Adenovirus-mediated wild-type p53 gene transfer into head and neck cancers / G.L. Clayman, D.K. Frank and P.A. Bruso-Direct DNA injection (p53) into hcc tumors / R.R. Mitry and N.A. Habib-A phase ii trial of intratumoral injection with a selectively replicating adenovirus (onyx-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck / D.H. Kirn-C-myb antisense oligonucleotide therapeutics for hematologic malignancies / S. Luger-Ovarian cancer gene therapy with brca1-an overview / P.S. Obermiller and J.T. Holt-Methods for chemoprotection and chemosensitization : Mdr-1 for chemoprotection using retroviruses to modify hematopoietic cells and cytosine deaminase for chemosensitization using adenoviral vectors to modify epithelian neoplastic cells / S. Shrimdkandada [and others]. |
| 506 ## - RESTRICTIONS ON ACCESS NOTE |
| Materials specified |
Use copy |
| Standardized terminology for access restriction |
Restrictions unspecified |
| Source of term |
star |
| Institution to which field applies |
MiAaHDL |
| 533 ## - REPRODUCTION NOTE |
| Type of reproduction |
Electronic reproduction. |
| Place of reproduction |
[Place of publication not identified] : |
| Agency responsible for reproduction |
HathiTrust Digital Library, |
| Date of reproduction |
2010. |
| Institution to which field applies |
MiAaHDL |
| 538 ## - SYSTEM DETAILS NOTE |
| System details note |
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |
| Uniform Resource Identifier |
<a href="http://purl.oclc.org/DLF/benchrepro0212">http://purl.oclc.org/DLF/benchrepro0212</a> |
| Institution to which field applies |
MiAaHDL |
| 583 1# - ACTION NOTE |
| Action |
digitized |
| Time/date of action |
2010 |
| Jurisdiction |
HathiTrust Digital Library |
| Status |
committed to preserve |
| Source of term |
pda |
| Institution to which field applies |
MiAaHDL |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
In Gene Therapy of Cancer: Methods and Protocols, Wolfgang Walther and Ulrike Stein survey the rapidly evolving field cancer gene therapy and provide a broad array of leading-edge protocols for the delivery of therapeutic genes into tumors. Described in step-by-step fashion and enriched with each author's own practical tips, these readily reproducible methods are currently being widely applied in cancer gene therapy investigations, including immunotherapy and tumor vaccination, suicide gene therapy, antioncogene therapy, and antisense and ribozyme gene therapy. Representative strategies are provided for gene targeting and for viral or nonviral gene delivery in cancer therapy, as well as a significant number of clinical protocols for the development of novel cancer gene therapies. Gene Therapy of Cancer: Methods and Protocols offers basic and clinical researchers a broad ranging overview and collection of the most recent advances in gene transfer techniques. Written by leading international authorities, its readily reproducible, cutting-edge methods constitute today's most valuable tools for the study of cancer gene therapy in both the laboratory and clinical trials. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Gene therapy |
| Form subdivision |
Laboratory manuals. |
| 9 (RLIN) |
80619 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
therapy |
| 9 (RLIN) |
80620 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Genetic Therapy |
| General subdivision |
methods |
| 9 (RLIN) |
80621 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Thérapie génique |
| Form subdivision |
Manuels de laboratoire. |
| 9 (RLIN) |
80622 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
MEDICAL |
| General subdivision |
Oncology. |
| Source of heading or term |
bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
HEALTH & FITNESS |
| General subdivision |
Diseases |
| -- |
Cancer. |
| Source of heading or term |
bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Gene therapy |
| Source of heading or term |
fast |
| 9 (RLIN) |
80625 |
| 650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Wetenschappelijke technieken. |
| Source of heading or term |
gtt |
| 655 #2 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Laboratory Manual |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Handbooks and manuals |
| Source of term |
fast |
| 9 (RLIN) |
6671 |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Laboratory manuals. |
| Source of term |
lcgft |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Manuels de laboratoire. |
| Source of term |
rvmgf |
| 9 (RLIN) |
966128 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Walther, Wolfgang. |
| 9 (RLIN) |
80627 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Stein, Ulrike. |
| 9 (RLIN) |
80628 |
| 773 0# - HOST ITEM ENTRY |
| Title |
Springer Protocols |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
| Relationship information |
Print version: |
| Title |
Gene therapy of cancer. |
| Place, publisher, and date of publication |
Totowa, N.J. : Humana Press, ©2000 |
| International Standard Book Number |
0896037142 |
| Record control number |
(DLC) 99038474 |
| -- |
(OCoLC)41945019 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Methods in molecular medicine ; |
| Volume number/sequential designation |
35. |
| 9 (RLIN) |
79864 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
<a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590861">https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590861</a> |
| 938 ## - |
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10181250 |
| 938 ## - |
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
46923 |
| 938 ## - |
| -- |
Internet Archive |
| -- |
INAR |
| -- |
genetherapyofcan0000unse |
| 938 ## - |
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
2360017 |
| 994 ## - |
| -- |
92 |
| -- |
ATIST |